QUÉBEC CITY, Oct. 7, 2014
/PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ)
(the "Company") today announced the appointment of
Philip A. Theodore, as Senior Vice
President, Chief Administrative Officer, General Counsel and
Corporate Secretary. Before joining Aeterna Zentaris,
Mr. Theodore was Vice President, General Counsel and Corporate
Secretary of Zep Inc., a leading consumable chemical packaged goods
company.
"We are very proud to welcome Philip to our leadership team, as
he will be responsible for overseeing the day-to-day duties with
respect to the administrative, legal, human resources, corporate
development and corporate secretary functions. In developing his
career, Philip has held increasingly responsible positions with
several leading companies. He has extensive experience in merger
and acquisition activities, integration of companies, management of
numerous litigation matters as well as in counselling corporate
management in regards to credit agreement negotiations, corporate
disclosure issues and general contract issues", said David Dodd, Chairman and CEO of Aeterna
Zentaris. "In his role, Phil will be an invaluable asset in
establishing the platform for value growth and development of our
Company."
Mr. Theodore added, "I am delighted to be joining Aeterna
Zentaris at this exciting watershed in its transition to an
operating specialty biopharmaceutical company. Clearly, the Company
is on a path to successfully become a commercial-oriented entity
and I look forward to working with the Aeterna Zentaris team in
building a successful and sustainable, competitive
organization."
Philip A. Theodore's
Background
Mr. Theodore is a graduate of the University of Cincinnati College of Law, and holds
a B.A. (Political Science) from the University
of Tennessee at Chattanooga.
Before joining Aeterna Zentaris, Philip
Theodore served as Vice President, General Counsel and
Corporate Secretary of Zep Inc., a leading global supplier of
consumable chemical packaged goods. Prior to joining Zep Inc., he
served as Vice President of Corporate Development, Compliance and
Legal for BioReliance, Inc. from September
2008 to April 2009; as Senior
Vice President and General Counsel of John H. Harland Company from
September 2006 to September 2007; and as Vice President, General
Counsel and Corporate Secretary of Serologicals Corporation from
2004 through August 2006.
Mr. Theodore also served as a partner in the corporate
practice of King & Spalding, LLP, an Atlanta-based law firm, from 1986 through
2003.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel treatments in
oncology and endocrinology. The Company's pipeline encompasses
compounds at various stages of development. For more information,
visit www.aezsinc.com.
Forward-Looking Statements
This press release contains forward-looking statements made
pursuant to the safe harbour provisions of the US Securities
Litigation Reform Act of 1995. Forward-looking statements involve
known and unknown risks and uncertainties that could cause the
Company's actual results to differ materially from those in the
forward-looking statements. Such risks and uncertainties include,
among others, the availability of funds and resources to pursue
R&D projects, the successful and timely completion of clinical
studies, the risk that safety and efficacy data from any of our
Phase 3 trials may not coincide with the data analyses from
previously reported Phase 1 and/or Phase 2 clinical trials, the
ability of the Company to efficiently commercialize one or more of
its products or product candidates, the ability of the Company to
take advantage of business opportunities in the pharmaceutical
industry, uncertainties related to the regulatory process and
general changes in economic conditions. Investors should consult
the Company's quarterly and annual filings with the Canadian and US
securities commissions for additional information on risks and
uncertainties relating to forward-looking statements. Investors are
cautioned not to rely on these forward-looking statements. The
Company does not undertake to update these forward-looking
statements. We disclaim any obligation to update any such factors
or to publicly announce the result of any revisions to any of the
forward-looking statements contained herein to reflect future
results, events or developments, unless required to do so by a
governmental authority or by applicable law.
SOURCE Aeterna Zentaris Inc.